By the end of this session participants will be able to:
1.Discuss Cannabis and Vaping – What to tell your patients
2.Immunization to prevent cardiac events – Evidence and which patients?
3.Determine when to order and how to interpret CT coronary calcium scores, Lipoprotein(a), and other advanced cardiovascular risk assessment tools
4.Apply current lipid management guidelines and make use of the peer simplified decision aid
5.Summarize the cardiovascular risks associated with cannabis and vaping use and counsel patients effectively on harm reduction and evidence-based recommendations.
6.Review current evidence linking immunization to cardiovascular event prevention and identify patients who may benefit most from vaccine-preventable risk reduction strategies.
